Table 2 Long-term complications by age group in 247 home-isolated patients with COVID-19 at 6-month follow-up

From: Long COVID in a prospective cohort of home-isolated patients

Characteristic All 0–15 years 16–30 years 31–45 years 46–60 years Over 60 years
% (n/N) % (n) % (n) % (n) % (n) % (n)
N = 247 N = 16 N = 61 N = 58 N = 67 N = 45
Age, median (IQR) 43 (27–55) 8 (6–12) 24(22–27) 37 (34–41) 53 (49–55) 67 (63–73)
Female gender 53% (131/247) 56% (9) 54% (33) 52% (30) 52% (35) 53% (24)
Status at 6 months       
Any symptoms 55% (136/247) 13% (2)* 52% (32) 59% (34) 61% (41) 60% (27)
Fever 2% (4/247) 0% (0) 0% (0) 5% (3) 1% (1) 0% (0)
Cough 6% (15/247) 0% (0) 0% (0) 9% (5) 4% (3) 16% (7)
Dyspnea 15% (38/247) 0% (0) 13% (8) 17% (10) 18% (12) 18% (8)
Palpitations 6% (15/247) 0% (0) 3% (2) 7% (4) 9% (6) 7% (3)
Stomach upset 6% (15/247) 6% (1) 5% (3) 7% (4) 6% (4) 7% (3)
Disturbed taste/smell 27% (67/247) 13% (2) 28% (17) 34% (20) 28% (19) 20% (9)
Fatigue 30% (69/231) - a 21% (13) 31% (18) 33% (22) 36% (16)
Concentration problems 19% (44/231) - a 13% (8) 19% (11) 21% (14) 24% (11)
Memory problems 18% (42/231) - a 11% (7) 16% (9) 22% (15) 24% (11)
Sleep problems 5% (13/247) 0% (0) 5% (3) 7% (4) 4% (3) 7% (3)
Headache 11% (28/247) 0% (0) 11% (7) 14% (8) 9% (6) 16% (7)
Dizziness 10% (24/247) 0% (0) 7% (4) 10% (6) 10% (7) 16% (7)
Tingling in fingers 4% (9/247) 0% (0) 0% (0) 2% (1) 4% (3) 11% (5)
  1. *Statistically significant difference at level P < 0.05 in univariable analysis using binomial logistic regression with age group 46–60 as reference group.
  2. aChildren younger than 16 years were not assessed for these symptoms; therefore, N = 231 for these categories.